QR Code

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma

COVID-19 is an ongoing pandemic with high morbidity and mortality. Despite meticulous research, only dexamethasone has shown consistent mortality reduction. Convalescent plasma (CP) infusion might also develop into a safe and effective treatment modality on the basis of recent studies and meta-analy...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Thomas P. Thomopoulos, Margherita Rosati, Evangelos Terpos, Dimitris Stellas, Xintao Hu, Sevasti Karaliota, Anthi Bouchla, Ioannis Katagas, Anastasia Antoniadou, Andreas Mentis, Sotirios G. Papageorgiou, Marianna Politou, Jenifer Bear, Duncan Donohue, Anastasia Kotanidou, Ioannis Kalomenidis, Eleni Korompoki, Robert Burns, Maria Pagoni, Elisavet Grouzi, Stavroula Labropoulou, Kostantinos Stamoulis, Aristotelis Bamias, Sotirios Tsiodras, Meletios-Athanasios Dimopoulos, George N. Pavlakis, Vasiliki Pappa, Barbara K. Felber
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2021-09-01
Rangatū:Viruses
Ngā marau:
convalescent plasma
SARS-CoV-2
COVID-19
antibody kinetics
neutralizing antibodies
spike
Urunga tuihono:https://www.mdpi.com/1999-4915/13/9/1844
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite